<?xml version="1.0" encoding="UTF-8"?>
<p>Before the introduction of measles immunization in the 1960s, almost everyone contracted measles usually during childhood with an estimated annual incidence of 130 million cases and an early mortality of 2.5 million each year. Since the introduction of the vaccine, the incidence of measles as well as the associated early mortality rate decreased. From 2000 to 2016, a 84% drop in mortality was noted from about 550,100 to 89,780 deaths, global annual reported incidence decreased by about 87% from 145 to 19 cases per million persons, estimates of the first dose of measles-containing vaccine (MCV1) coverage increased globally from 72% to 85% and the number of countries providing second dose of measles-containing vaccine (MCV2) nationally through routine services increased from 98 (51%) to 164 (85%) in which 24 African countries [
 <xref rid="pone.0222428.ref005" ref-type="bibr">5</xref>]. Despite this progress, epidemics have continued in some regions. In 2016, of the 89,780 deaths attributed to measles, 85% occurred in Africa and Asia [
 <xref rid="pone.0222428.ref005" ref-type="bibr">5</xref>].
</p>
